Pharmaceutical

Aspect Biosystems receives funding for cellular medicin...

The project will enhance Aspect Biosystems’ clinical development capabilities an...

Leading people in the age of AI

As AI reshapes pharma, HR leadership is being drawn into a deeper question that...

MSD secures EC clearance for Keytruda combination thera...

The approval in the European Union (EU) is for adults with platinum-resistant ep...

Patent expiries ahead, is India Pharma Inc ready?

Beyond the semaglutide momentum, a larger wave of patent expiries is set to unf...

Emcure Pharmaceuticals revises price of Poviztra semagl...

Weight management drug to be available from Rs 3,999 per month from April 3, 20...

Mumbai Experience Center reflects Agilent’s continued c...

Bharat Bhardwaj, Vice President, Asia Pacific, Agilent Technologies spoke to Vi...

Agilent expands India’s scientific ecosystem with new c...

Agilent Technologies has announced the opening of its Customer Experience Cente...

Glenmark to manage end-to-end commercialisation and dis...

RYALTRIS is Glenmark’s first innovative product introduced into the US market T...

Lupin completes acquisition of VISUfarma

The integration of VISUfarma has expanded Lupin’s ophthalmology portfolio to ov...

Merck KGaA acquires JSR chromatography business

This follows the company’s signing of a definitive agreement in October 2025 to ...

Biocytogen and Sihuan partner to advance new therapeuti...

Under the agreement, Biocytogen’s fully human antibody discovery platform will b...

Telomir seeks FDA approval for Telomir-1 to treat breas...

The IND includes results from completed toxicology, pharmacology, and manufactur...

Symeres and Ambagon collaborate for colorectal cancer m...

The partnership aims to explore a new class of small molecules, called molecular...

Enthral.ai partners with Alembic Pharmaceuticals to dep...

Platform to support compliance, training and documentation for over 9,000 lear...

Express Pharma April 2026

India's Foremost Pharma & Biotech Magazine ~ Patent Expiries Ahead: Is India Ph...

Midst global headwinds, CDSCO cracks down on GLP-1 gold...

As pharma companies deal with price wars, increasing regulatory heat and a vola...